The Use of Dexamethasone in Total Thyroidectomy to Improve Voice Outcome and Hypocalcaemia
Voice Change, Hypocalcemia
About this trial
This is an interventional prevention trial for Voice Change focused on measuring Voice dysfunction, Hoarseness of Voice, Vocal cord palsy, Hypocalcemia, Hypoparathyroidism, Thyroidectomy, Dexamethasone, Steroid
Eligibility Criteria
Inclusion Criteria: Aged 18 or above Patients undergoing total thyroidectomy for benign pathologies MNG Toxic nodular goitre Graves' disease Exclusion Criteria: Non-communicable patients Patients contraindicated for steroid (DM, Hepatitis carrier, Tuberculosis, peptic ulcer disease) Patients contraindicated for analgesics including Panadol, Celebrex, Tramadol or Levobupivacaine Malignant thyroid disease Patients with previous thyroid surgery, or neck surgery Pre-existing hoarseness of voice of any cause or pre-existing vocal cord palsy Pregnancy / Lactating female patients Pre-existing renal disease / autoimmune disease on steroids Patients who require steroid cover during operation e.g. hydrocortisone perioperatively
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Dexamethasone group
Placebo group
One dose of 8mg in 2ml Dexamethasone will be given
One dose of 2ml 0.9% Normal saline will be given